Aclaris Therapeutics (ACRS) – Analyst Comments
-
Leerink Partners Downgrades Aclaris Therapeutis (ACRS) to Market Perform
-
Piper Sandler Downgrades Aclaris Therapeutis (ACRS) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ACRS Stock Lookup